Last reviewed · How we verify
CN54gp140 mixed with GLA-AF
At a glance
| Generic name | CN54gp140 mixed with GLA-AF |
|---|---|
| Sponsor | Imperial College London |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CN54gp140 mixed with GLA-AF CI brief — competitive landscape report
- CN54gp140 mixed with GLA-AF updates RSS · CI watch RSS
- Imperial College London portfolio CI